Orion Oyj

Chart & performance

D1W1MN

P/E

22.46

P/S

5.95

EPS

3.55

Div yield, %

2.05%

Shrs. gr., 5y

0.02%

Rev. gr., 5y

11.88%

Revenues

Net income

CFO

Dividend

Oct 19, 20260.9 EUR/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.

URL

https://www.orion.fi/

IPO date

Jul 03, 2006

Employees

3,657

Domiciled in

Incorporated in

Valuation

No data to show